New insights into functional regulation in MS-based drug profiling

We present a novel data analysis strategy which combined with subcellular fractionation and liquid chromatography-mass spectrometry (LC-MS) based proteomics provides a simple and effective workflow for global drug profiling. Five subcellular fractions were obtained by differential centrifugation followed by high resolution LC-MS and complete functional regulation analysis. The methodology combines functional regulation and enrichment analysis into a single visual summary. The workflow enables improved insight into perturbations caused by drugs. We provide a statistical argument to demonstrate that even crude subcellular fractions leads to improved functional characterization. We demonstrate this data analysis strategy on data obtained in a MS-based global drug profiling study. However, this strategy can also be performed on other types of large scale biological data.

Estudo e Coordenação das Principais Protecções Eléctricas de Geradores e Transformadores de uma Central de Cogeração

O Sector eléctrico possui uma grande importância nas sociedades modernas. Dados os elevados custos de produção de energia e o grande impacto que esta tem na nossa economia e na sociedade, em geral, a utilização mais eficiente da energia é um factor fulcral. Com a evolução da electrónica e consequente aumento das capacidades dos computadores, as protecções eléctricas são cada vez mais eficazes e com índices de fiabilidade mais elevados, algo muito importante em instalações de elevado custo de investimento e manutenção. No entanto, o seu bom funcionamento está dependente do correcto dimensionamento das protecções e de uma análise técnica capaz de prever necessidades futuras. Após uma breve introdução no capítulo 1 é efectuado no capítulo 2 um breve estudo de protecções eléctricas e o seu estado de arte. Nos Capítulos 3 e 4 é efectuado o dimensionamento e estudo da selectividade das protecções de grupo de Alternador e Transformador escolhidos para a nova central de cogeração da refinaria de Matosinhos da Galp. No presente estudo foram apenas consideradas as protecções típicas de alternador e apenas a protecção diferencial do transformador. Todas as protecções foram dimensionadas com base no tutorial de protecções de geradores do IEE e com informação referente ao manual de instruções do relé G60 da GE industrial systems, o DTP-B da GE multilin e o ELIN Power Plant Automation. No Capítulo 5 é demonstrada a importância da análise Safety Instruments Systems (SIS), o seu modo de aplicação e necessidade de implementação em locais industriais como o caso em estudo. Por último, é efectuado um pequeno estudo económico onde é efectuada a comparação dos custos dos diversos equipamentos, protecções e manutenções efectuadas.

Calcium signaling and the novel anti-proliferative effect of the UTP-sensitive P2Y11 receptor in rat cardiac myofibroblasts

During myocardial ischemia and reperfusion both purines and pyrimidines are released into the extracellular milieu, thus creating a signaling wave that propagates to neighboring cells via membrane-bound P2 purinoceptors activation. Cardiac fibroblasts (CF) are important players in heart remodeling, electrophysiological changes and hemodynamic alterations following myocardial infarction. Here, we investigated the role UTP on calcium signaling and proliferation of CF cultured from ventricles of adult rats. Co-expression of discoidin domain receptor 2 and -smooth muscle actin indicate that cultured CF are activated myofibroblasts. Intracellular calcium ([Ca2+]i) signals were monitored in cells loaded with Fluo-4 NW. CF proliferation was evaluated by the MTT assay. UTP and the selective P2Y4 agonist, MRS4062, caused a fast desensitizing [Ca2+]i rise originated from thapsigargin-sensitive internal stores, which partially declined to a plateau providing the existence of Ca2+ in the extracellular fluid. The biphasic [Ca2+]i response to UTP was attenuated respectively by P2Y4 blockers, like reactive blue-2 and suramin, and by the P2Y11 antagonist, NF340. UTP and the P2Y2 receptor agonist MRS2768 increased, whereas the selective P2Y11 agonist NF546 decreased, CF growth; MRS4062 was ineffective. Blockage of the P2Y11receptor or its coupling to adenylate cyclase boosted UTP-induced CF proliferation. Confocal microscopy and Western blot analysis confirmed the presence of P2Y2, P2Y4 and P2Y11 receptors. Data indicate that besides P2Y4 and P2Y2 receptors which are responsible for UTP-induced [Ca2+]i transients and growth of CF, respectively, synchronous activation of the previously unrecognized P2Y11 receptor may represent an important target for anti-fibrotic intervention in cardiac remodeling.

Acellular and "low" pertussis vaccines: adverse events and the role of mutations

Objective: to discuss the current PAHO recommendation that does not support the substitution of traditional cellular DTP vaccine by acellular DTP, and the role of mutations, in humans, as the main cause of rare adverse events, such as epileptic-like convulsions, triggered by pertussis vaccine. Data review: the main components related to toxic effects of cellular pertussis vaccines are the lipopolysaccharide of bacterial cell wall and pertussis toxin. The removal of part of lipopolysaccharide layer has allowed the creation of a safer cellular pertussis vaccine, with costs comparable to the traditional cellular vaccine, and which may be a substitute for the acellular vaccine. Conclusion: The new methodology introduced by Instituto Butantan allows for the development of a new safer pertussis vaccine with low LPS content (Plow), and the use of the lipopolysaccharide obtained in the process in the production of monophosphoryl lipid A. This component has shown potent adjuvant effect when administered together with influenza inactivated vaccine, making possible to reduce the antigen dose, enhancing the production capacity and lowering costs.

HDL in HIV-1 infection: a quality perspective through paraoxonase-1 activities

Dissertação para obtenção do Grau de Mestre em Genética Molecular e Biomedicina

Caracterização de novas tipologias de fibras sintéticas

Este estudo realizou-se nas instalações da FISIPE e teve como objectivo a caracterização de novas tipologias de fibras, no âmbito do controlo do processo e da qualidade do produto final. Assim, pretendeu-se cumprir os seguintes objectivos: i. Validação da substituição dos viscosímetros de Cannon-Fenske por viscosímetros de Ubbelohde; ii. Caracterização da granulometria para uma nova tipologia de fibra; iii. Caracterização da densidade aparente de um novo polímero; iv. Desenvolvimento de uma técnica de quantificação de comonómeros vinílicos; v. Quantificação da porosidade da fibra de poliacrilonitrilo (PAN). No âmbito do objectivo i., concretizaram-se medições de viscosidade manuais recorrendo a viscosímetros de Ubbelohde. Verificou-se que esta propriedade não influencia os valores de especificação de NSP estabelecidos, pelo que é possível a substituição dos viscosímetros de Cannon-Fenske por viscosímetros de Ubbelohde. Para análise da evolução da granulometria, do novo polímero em estudo, ao longo da reacção de polimerização, variou-se a proporção água/monómero. Não foi possível obter-se uma distribuição de tamanhos de partícula (DTP) monodispersa, pelo que se conclui que nos estudos efectuados não se atingiu o estado estacionário em termos de distribuição granulométrica. A densidade aparente foi medida para avaliação do seu impacto na transferência (por transporte pneumático) e armazenamento do polímero. Este parâmetro é particularmente relevante no dimensionamento dos silos de armazenagem. Verificou-se que o novo polímero tem uma menor densidade aparente e consequentemente ocupa maior volume comparativamente ao polímero padrão. Portanto, silos de armazenagem de dimensão similar aos actuais irão armazenar uma menor quantidade do novo polímero. Estudou-se uma técnica de quantificação de comonómeros vinílicos. Verificou-se que os tempos das reacções e de banho de gelo influenciam os resultados finais, bem como, possivelmente, as condições de armazenagem dos reagentes. Devido à insuficiência de tempo, não foi possível validar o método. A porosidade da fibra de poliacrilonitrilo (PAN) foi caracterizada por picnometria de hélio. Concluiu-se que esta técnica não é sensível a esta análise. Por porosimetria de mercúrio e adsorção de azoto, verificou-se a inexistência de poros abertos na fibra PAN.

Differential time to positivity of blood cultures: a valid method for diagnosing catheter-related bloodstream infections in the intensive care unit

iii. Catheter-related bloodstream infection (CR-BSI) diagnosis usually involves catheter withdrawal. An alternative method for CR-BSI diagnosis is the differential time to positivity (DTP) between peripheral and catheter hub blood cultures. This study aims to validate the DTP method in short-term catheters. The results show a low prevalence of CR-BSI in the sample (8.4%). The DTP method is a valid alternative for CR-BSI diagnosis in those cases with monomicrobial cultures (80% sensitivity, 99% specificity, 92% positive predictive value, and 98% negative predictive value) and a cut-off point of 17.7 hours for positivity of hub blood culture may assess in CR-BSI diagnosis.

Clinical application of differential time to positivity of blood cultures as a diagnostic method for catheter-related bloodstream infection.

La sospita de bacterièmia relacionada a catèter (BRC) necessita la retirada d’aquest, confirmant-se a posteriori només en un 15-25%. La diferencia en el temps de positivització d´ hemocultius (DTP) ha demostrat ser un mètode fiable per el diagnòstic de BRC evitant la retirada del catèter. Amb la intenció de comprovar la utilitat clínica de la DTP, l’hem comparada amb un mètode diagnòstic estàndard. Hem inclòs 133 pacients ingressats a una unitat de cures intensives portadors de catèters venosos centrals. 56 pacients s’han aleatoritzats. No hem trobat diferències significatives en quant a morbi-mortalitat en els 2 grups havent evitat 70% de retirada innecessària de catèters en el grup de DTP.

Immunogenicity test of tetanus component in adsorbed vaccines by toxin binding inhibition test

Samples from 20 lots of diphtheria-tetanus (adult use dT) vaccine and from 20 lots of diphtheria-tetanus-pertussis (DTP) vaccine were used to standardize and validate the in vitro toxin binding inhibition (ToBI) test for the immunogenicity test of the tetanus component. The levels of tetanus antitoxin obtained by ToBI test were compared to those obtained using the toxin neutralization (TN) test in mice routinely employed to perform the quality control of the tetanus component in adsorbed vaccines. The results ranged from 1.8 to 3.5 IU/ml for dT and 2 to 4 IU/ml for DTP by ToBI test and 1.4 to 3 IU/ml for dT and 1.8 to 3.5 IU/ml for DTP by TN in mice. These results were significantly correlated. From this study, it is concluded that the ToBI test is an alternative to the in vivo neutralization procedure in the immunogenicity test of the tetanus component in adsorbed vaccines. A substantial refinement and a reduction in use of animals can be achieved.

Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b

A randomized, double-blinded study evaluating the immunogenicity, safety and consistency of production of a combined diphtheria-tetanus-pertussis-Haemophilus influenzae type b vaccine entirely produced in Brazil by Bio-Manguinhos and Instituto Butantan (DTP/Hib-BM) was undertaken. The reference vaccine had the same DTP vaccine but the Hib component was produced using purified materials supplied by GlaxoSmithKline (DTP/Hib-GSK), which is registered and has supplied the Brazilian National Immunization Program for over more than five years. One thousand infants were recruited for the study and received vaccinations at two, four and six months of age. With respect to immunogenicity, the vaccination protocol was followed in 95.6% and 98.4% of infants in the DTP/Hib-BM and DTP/Hib-GSK groups, respectively. For the Hib component of the study, there was 100% seroprotection (>0.15 µg/mL) with all three lots of DTP/Hib-BM and DTP/Hib-GSK. The geometric mean titer (GMT) was 9.3 µg/mL, 10.3 µg/mL and 10.3 µg/mL for lots 1, 2 and 3 of DTP/Hib-BM, respectively, and the GMT was 11.3 g/mL for DTP/Hib-GSK. For diphtheria, tetanus and pertussis, seroprotection was 99.7%, 100% and 99.9%, respectively, for DTP/Hib-BM, three lots altogether and 99.2%, 100% and 100% for DTP/Hib-GSK. GMTs were similar across all lots and vaccines. Adverse events rates were comparable among the vaccine groups. The Brazilian DTP/Hib vaccine demonstrated an immunogenicity and reactogenicity profile similar to that of the reference vaccine.

Tapahtumankäsittely hajautetussa ympäristössä

Tapahtumankäsittelyä pidetään yleisesti eräänä luotettavan tietojenkäsittelyn perusvaatimuksena. Tapahtumalla tarkoitetaan operaatiosarjaa, jonka suoritusta voidaan pitää yhtenä loogisena toimenpiteenä. Tapahtumien suoritukselle on asetettu neljä perussääntöä, joista käytetään lyhennettä ACID. Hajautetuissa järjestelmissä tapahtumankäsittelyn tarve kasvaa entisestään, sillä toimenpiteiden onnistumista ei voida varmistaa pelkästään paikallisten menetelmien avulla. Hajautettua tapahtumankäsittelyä on yritetty standardoida useaan otteeseen, muttayrityksistä huolimatta siitä ei ole olemassa yleisesti hyväksyttyjä ja avoimia standardeja. Lähimpänä tällaisen standardin asemaa on todennäköisesti X/Open DTP-standardiperhe ja varsinkin siihen kuuluva XA-standardi. Tässä työssä on lisäksi tutkittu, kuinka Intellitel ONE-järjestelmän valmistajariippumatonta tietokanta-arkkitehtuuria tulisi kehittää, kun tavoitteena on mahdollistaa sen avulla suoritettavien tapahtumankäsittelyä vaativien sovellusten käyttäminen.

Pk-yrityksen polku systemaattiseen tuote- ja elinkaaritiedon hallintaan

Tutkimus on tehty Tekesin DTP-ohjelman Sinfonet-tutkimusprojektin puitteissa aikavälillä 2009-2011. Työssä on laadittu kokonaisvaltainen tuote- ja elinkaaritiedon hallinnan (eng. Product Lifecycle Management, PLM) tiekartta ja kehityssuunnitelma pienelle engineering-yritykselle. Työ käsittelee asiakkaan erikoisvaatimusten mukaan räätälöitävän tuotteen tuote- ja elinkaaritiedon hallinnan systematisointia pk-yrityksessä. Vaikka PLM-tiekartta on laadittu yksittäiselle yritykselle, sitä voidaan tietyin edellytyksin soveltaa myös toisten pk-yritysten tai engineeringyritysten PLM:n kehittämiseen. Teoriassa tarkastellaan ensinnäkin kohdeyritykseen liittyviä erityispiirteitä, pyritään ymmärtämään engineering–yrityksen ja pk-yrityksen erikoispiirteitä sekä niiden vaikutusta PLM:n kehittämiseen. Toiseksi esitellään PLM:n viittä keskeistä osaaluetta, yksi- ja viisiulotteisten PLM-kypsyysmallien käyttöä yrityksen nykytilan arvioimiseksi sekä rakennetaan engineering-yrityksen kokonaisvaltainen PLM-malli ja kahdeksan askeleen PLM-kehityspolku. PLM-malli jäsentää tiedonhallintaa prosessien kautta ja se koostuu viidestä osaalueesta: strategia identifioi asiakastarpeet sekä määrittelee kuinka tuotteiden ja prosessien avulla asiakastarpeet tyydytetään; prosessit ovat yrityksen toiminnan ydin, joissa tuotemallit ja tuote- ja tietorakenteet kehitetään sekä tuoteyksilöt toimitetaan asiakkaalle; rakenteet pohjautuvat strategiassa valittuun tuote- ja tiedonhallinnan strategiaan ja niiden tehtävänä on tukea ja tehostaa toimintaprosesseja; kulttuuri ja ihmiset muodostavat aineettoman pääoman, jonka vaikutuksesta prosessit toimivat ja tuotteet pystytään toimittamaan asiakkaalle; informaatioteknologia on työkalu, jota käytetään prosesseissa ja tietorakenteiden ylläpidossa, pääosin dokumentoidun tiedon luomiseen, hankitaan, varastoimiseen, jakamiseen ja soveltamiseen. Tapaustutkimuksessa kuvataan kohdeyrityksen nykytilaa PLM:n viidellä keskeisellä osa-alueella, tehdään PLM kypsyysarvio kahdella menetelmällä, määritellään yrityksen tavoitetila ja laaditaan yritykselle ensin alustava PLM roadmap ja lopulta kokonaisvaltaiseen PLM-malliin perustuva PLM roadmap ja PLM:n jatkokehityssuunnitelma.

Evolution of Bordetella pertussis post vaccination

Evolution of Bordetella pertussis post vaccination Whooping cough or pertussis is caused by the gram-negative bacterium Bordetella pertussis. It is a highly contiguous disease in the human respiratory tract. Characteristic of pertussis is a paroxysmal cough with whooping sound during gasps of breath after coughing episodes. It is potentially fatal to unvaccinated infants. The best approach to fight pertussis is to vaccinate. Vaccinations against pertussis have been available from the 1940s. Traditionally vaccines were whole-cell pertussis (wP) preparations as part of the combined diphtheria-tetanus-pertussis (DTP) vaccines. More recently acellular pertussis (aP) vaccines have replaced the wP vaccines in many countries. The aP vaccines are less reactogenic and can also be administered to school children and adults. There are several publications reporting variation in the i>B. pertussis virulence factors that are also aP vaccine antigens. This has occurred in the genes coding for pertussis toxin and pertactin about 15 to 30 years after the introduction of pertussis vaccines to immunisation programs. Resurgence of pertussis has also been reported in many countries with high vaccination coverage. In this study the evolution of B. pertussis was investigated in Finland, the United Kingdom, Poland, Serbia, China, Senegal and Kenya. These represent countries with a long history of high vaccination coverage with stable vaccines or changes in the vaccine formulation; countries which established high vaccination coverage late; and countries where vaccinations against pertussis were started late. With bacterial cytotoxicity and cytokine measurements, comparative genomic hybridisation, pulsed-field gel electrophoresis (PFGE), genotyping and serotyping it was found that changes in the vaccine composition can postpone the emergence of antigenic variants. It seems that the change in PFGE profiles and the loss of genetic material in the genome of B. pertussis are similar in most countries and the vaccine-induced immunity is selecting non-vaccine type strains. However, the differences in the formulation of the vaccines, the vaccination programs and in the coverage of pertussis vaccination have affected the speed and timing of these changes.

Determination of collector chemicals from flotation process waters using capillary electrophoresis

Vaahdotusprosessia käytetään yleisesti erottamaan arvokkaita mineraaleja malmeista. Toimiakseen tehokkaasti prosessi tarvitsee kokoojakemikaaleja, joiden tehtävänä on sitoa halutut mineraalit ilmakupliin. Jotta näiden kemikaalien käyttäytymistä prosessissa voitaisiin ymmärtää paremmin ja prosessin ohjausta tehostaa, pitää kokoojia pystyä analysoimaan prosessivesistä. Työn kirjallisuusosassa on koottu ja vertailtu erilaisia kirjallisuudesta löytyneitä analyysimenetelmiä kokoojakemikaaleille. Kokeellisessaosassa on kehitetty kaksi kapillaarielektroforeesimenetelmää näiden kemikaalien tutkimiseen. Menetelmien toteamisrajat tutkituille kemikaaleille olivat seuraavanlaiset: natrium diiosobutylditiofosfaattille (DTP) 2,7 mg/L puhtaassa vedessä ja 6,7 mg/L prosessivedessä; natrium diisobutyldithiofosfinaatille (DTPI) vastaavasti 4,5 mg/L ja 6,7 mg/L; etyyli ksantaatille 0,025 mg/L ja 0,16 mg/L; ja isobutyyli ksantaatille 0,41 mg/L ja 0,62 mg/L. Näitä menetelmiä voidaan tulevaisuudessa kehittää kokoojien hajoamistuotteiden analysointia varten sekä prosessien on-line mittauksiin.

Pattern of functional antibody activity against Haemophilus influenzae type b (Hib) in infants immunized with diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine

We evaluated the functional activity of Haemophilus influenzae B (Hib) antibodies elicited in a group of infants immunized with the diphtheria-tetanus-pertussis vaccine combined with an Hib vaccine produced totally in Brazil after technological transfer of Hib vaccine production from Glaxo SmithKline, Belgium. Blood samples from immunized infants (N = 985) were collected for the determination of Hib antibodies. Total Ig and IgM and IgG subclasses of antibodies against polyribosyl ribitol phosphate (PRP) were analyzed by ELISA. Almost all vaccinees (97.56%, 961/985) developed a strong anti-PRP IgG antibody response (≥1.0 μg/mL), while an anti-PRP IgM response was observed in 64.24% (634/985) of them (≥0.15 μg/mL). Only 18.88% (186/985) of the infants in the group with high PRP antibody IgG concentrations (≥1.0 μg/mL) developed a high IgM antibody response. Anti-PRP IgG antibody levels were significantly higher than anti-PRP IgM. These results demonstrate the predominance of IgG antibodies over IgM antibodies in response to PRP, with a ratio of 17:1. IgG antibodies were predominantly of the IgG1 subclass. An increase in IgG avidity was also observed during the course of immunization.